ShiraTronics begins clinical trials, raises $5M for chronic migraine relief

Along its journey to treat chronic migraine patients, ShiraTronics raised $5 million as an extension to its Series A funding.

The capital helps the Brooklyn Park-based startup as it embarks on its first in-human studies, which is currently underway in Australia and is expected to conclude late this year or early next year.